The effects of hypertension as an existing comorbidity on mortality rate in patients with COVID-19 A systematic review and meta-analysis
View ORCID ProfileElena Whiteman
doi: https://doi.org/10.1101/2020.11.16.20149377
Elena Whiteman
Warwick Medical School, University of Warwick, Medical School Building, Coventry, CV4 7HL
BSc MScRoles: Medical Student
Data Availability
All data that is relevant to this research is available within the main text or supplementary material
Posted November 17, 2020.
The effects of hypertension as an existing comorbidity on mortality rate in patients with COVID-19 A systematic review and meta-analysis
Elena Whiteman
medRxiv 2020.11.16.20149377; doi: https://doi.org/10.1101/2020.11.16.20149377
Subject Area
Subject Areas
- Addiction Medicine (404)
- Allergy and Immunology (713)
- Anesthesia (208)
- Cardiovascular Medicine (2973)
- Dermatology (254)
- Emergency Medicine (446)
- Epidemiology (12828)
- Forensic Medicine (12)
- Gastroenterology (834)
- Genetic and Genomic Medicine (4626)
- Geriatric Medicine (424)
- Health Economics (733)
- Health Informatics (2945)
- Health Policy (1074)
- Hematology (394)
- HIV/AIDS (935)
- Medical Education (430)
- Medical Ethics (116)
- Nephrology (476)
- Neurology (4423)
- Nursing (238)
- Nutrition (653)
- Oncology (2299)
- Ophthalmology (654)
- Orthopedics (260)
- Otolaryngology (327)
- Pain Medicine (284)
- Palliative Medicine (85)
- Pathology (503)
- Pediatrics (1201)
- Primary Care Research (503)
- Public and Global Health (7014)
- Radiology and Imaging (1551)
- Respiratory Medicine (922)
- Rheumatology (446)
- Sports Medicine (386)
- Surgery (491)
- Toxicology (60)
- Transplantation (213)
- Urology (185)